Zydus Lifesciences - Quaterly Results

12 Nov 2024 Evaluate
The Revenue for the quarter ended  September 2024 of Rs. 26206.00 millions grew by 21.36 % from Rs. 21593.00 millions.The Company's Net profit for the September 2024 quarter have declined marginally to Rs. 7898.00  millions as against Rs. 8050.00 millions reported during the corresponding quarter ended.Operating Profit saw a handsome growth to 12689.00 millions from 11839.00 millions in the quarter ended September 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 26206.00 21593.00 21.36 67808.00 51150.00 32.57 108187.00 87316.00 23.90
Other Income 3813.00 6212.00 -38.62 4879.00 7036.00 -30.66 11595.00 8219.00 41.08
PBIDT 12689.00 11839.00 7.18 37484.00 24073.00 55.71 51435.00 30028.00 71.29
Interest 959.00 909.00 5.50 2113.00 1806.00 17.00 3907.00 2782.00 40.44
PBDT 11730.00 10930.00 7.32 35371.00 22267.00 58.85 47442.00 25208.00 88.20
Depreciation 1337.00 1249.00 7.05 2643.00 2461.00 7.40 5044.00 4886.00 3.23
PBT 10393.00 9681.00 7.35 32728.00 19806.00 65.24 42398.00 20322.00 108.63
TAX 2495.00 1631.00 52.97 7822.00 3947.00 98.18 7983.00 5030.00 58.71
Deferred Tax 9.00 -85.00 -110.59 20.00 -133.00 -115.04 -1360.00 412.00 -430.10
PAT 7898.00 8050.00 -1.89 24906.00 15859.00 57.05 34415.00 15292.00 125.05
Equity 1006.00 1012.00 -0.59 1006.00 1012.00 -0.59 1006.00 1012.00 -0.59
PBIDTM(%) 48.42 54.83 -11.69 55.28 47.06 17.46 47.54 34.39 38.25

Zydus Lifesciences Share Price

973.90 -11.80 (-1.20%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.